Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by barmac6on Apr 27, 2012 11:26am
162 Views
Post# 19843993

Branham300 List

Branham300 List

Hemisphere GPS Recognized on Branham300 List as one of Canada’s Top

Information and Communication Technology Companies

Calgary, AB – April 26, 2012 – (TSX:HEM) Hemisphere GPS’ commitment to growth and

innovation throughout 2011 has landed the company a spot on the Branham300 List for the

fifth consecutive year. Hemisphere GPS is ranked 68th among the top 250 Canadian

Information and Communication Technology (ICT) companies recognized. The Branham

Group also named Hemisphere GPS as a Top 10 Wireless Solutions Company in Canada.

“Over the last few years, we have focused on accelerating our product development process

and increasing our new product innovation,” says Steven Koles, President and CEO of

Hemisphere GPS. “Now, we are starting to see our investment in these areas pay off through

increased sales and revenue.”

With an 18-year reputation as a benchmark for technology firms, the Branham300 List is the

most comprehensive source on the health of the Canadian ICT sector. The annual

Branham300 List is published in the April/May edition of Backbone Magazine, as well as The

Globe and Mail.

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse